KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 74 filers reported holding KINNATE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,650,900 | +2.5% | 4,264,144 | 0.0% | 0.60% | +14.2% |
| Q4 2022 | $26,011,278 | -49.0% | 4,264,144 | 0.0% | 0.53% | -51.4% |
| Q3 2022 | $50,956,000 | -5.2% | 4,264,144 | 0.0% | 1.09% | -24.2% |
| Q2 2022 | $53,771,000 | +12.0% | 4,264,144 | 0.0% | 1.43% | +36.8% |
| Q1 2022 | $48,014,000 | -24.6% | 4,264,144 | +18.7% | 1.05% | -6.7% |
| Q4 2021 | $63,669,000 | -23.0% | 3,593,052 | 0.0% | 1.12% | -2.0% |
| Q3 2021 | $82,712,000 | -1.1% | 3,593,052 | 0.0% | 1.15% | -14.7% |
| Q2 2021 | $83,646,000 | -25.3% | 3,593,052 | 0.0% | 1.34% | -20.4% |
| Q1 2021 | $111,960,000 | -21.7% | 3,593,052 | 0.0% | 1.69% | -15.5% |
| Q4 2020 | $142,932,000 | – | 3,593,052 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |